The WHO global health sector strategy on sexually transmitted infections, 2016–2021,
endorsed by the World Health Assembly in 2016, aims to eliminate STIs as a public health …

Background The role of the human microbiome in health and disease is an emerging and
important area of research; however, there is a concern that African populations are under …

We characterized the vaginal ecosystem during common infections of the female genital
tract, as vulvovaginal candidiasis (VVC, n= 18) and Chlamydia trachomatis infection (CT, n …

Bacterial vaginosis (BV) is a common yet poorly understood vaginal condition that has
become a major focus of HIV transmission and immunology research. Varied terminologies …

The female reproductive tract harbours hundreds of bacterial species and produces
numerous metabolites. The uterine cervix is located between the upper and lower parts of …

The female genital tract microbiota is part of a complex ecosystem influenced by several
physiological, genetic, and behavioral factors. It is uniquely linked to a woman's mucosal …

Although Lactobacillus crispatus–dominated vaginal microbiotas are thought to protect
against bacterial vaginosis (BV) and sexually transmitted infections, the role of Lactobacillus …

Dysbiosis in the female genital tract (FGT) is characterized by the overgrowth of pathogenic
bacterial, fungal, or protozoan members of the microbiota, leading to symptomatic or …

Microbial communities inhabiting the human body play a crucial role in protecting the host
against pathogens and inflammation. Disruptions to the microbial composition can lead to …

Vaginal drug delivery represents an attractive alternative to achieve local and systemic
effects due to the high contact surface exposed, the mucoadhesion of the epithelium, and …